Sorrento Therapeutics, Inc. 4
4 · Sorrento Therapeutics, Inc. · Filed Jan 24, 2014
Insider Transaction Report
Form 4
Salka Michael Scott
Director
Transactions
- Award
Stock Options
2014-01-23+10,000→ 38,000 totalExercise: $9.82Exp: 2024-01-23→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]3,333 of the original number of shares subject to this option shall vest and become exercisable on January 23, 2015 and 2016 and 3,334 shall vest and become exercisable on January 23, 2017, subject to the reporting person's continued service on the issuer's board of directors on each such date.